Cochlear implant candidacy has expanded significantly as technology has improved. In the pediatric population, the FDA has approved implantation for children as young as 9 to 12 months with profound sensorineural hearing loss. Early intervention is critical because the "critical period" for language acquisition is highly dependent on early auditory stimulation. Children who receive implants early often achieve speech and language development comparable to their hearing peers.

In adults, candidacy is typically determined by speech perception scores rather than just pure-tone audiometry. Patients who score poorly on sentence recognition tests (usually <50% in the ear to be implanted) despite optimized hearing aids are considered candidates. To explore the shifts in clinical guidelines and the rising adoption of "Bilateral Implantation" (both ears), refer to the Cochlear Implants Market research. Bilateral implants provide significant advantages in "Sound Localization" and "Speech-in-Noise" understanding, which are primary challenges for unilateral users.

Recent clinical trends have also moved toward "Single-Sided Deafness" (SSD) candidacy. In these cases, the implant restores binaural hearing, which can significantly reduce the cognitive load associated with listening and improve the quality of life for patients who previously had no functional hearing on one side.